SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-013361
Filing Date
2024-02-09
Accepted
2024-02-09 17:00:21
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 11404
  Complete submission text file 0000950170-24-013361.txt   12901
Mailing Address DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
ADELMAN BURT A (Reporting) CIK: 0001226283 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-40489 | Film No.: 24615910

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)